IL318382A - Crystalline forms of an akr1c3 dependent kars inhibitor - Google Patents

Crystalline forms of an akr1c3 dependent kars inhibitor

Info

Publication number
IL318382A
IL318382A IL318382A IL31838225A IL318382A IL 318382 A IL318382 A IL 318382A IL 318382 A IL318382 A IL 318382A IL 31838225 A IL31838225 A IL 31838225A IL 318382 A IL318382 A IL 318382A
Authority
IL
Israel
Prior art keywords
kars
inhibitor
crystalline forms
akr1c3
dependent
Prior art date
Application number
IL318382A
Other languages
Hebrew (he)
Inventor
Danuta Lubicka
Michael Mutz
Yuling Zhu
Original Assignee
Novartis Ag
Danuta Lubicka
Michael Mutz
Yuling Zhu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Danuta Lubicka, Michael Mutz, Yuling Zhu filed Critical Novartis Ag
Publication of IL318382A publication Critical patent/IL318382A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4747—Quinolines; Isoquinolines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Earth Drilling (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL318382A 2022-07-26 2023-07-20 Crystalline forms of an akr1c3 dependent kars inhibitor IL318382A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2022107941 2022-07-26
PCT/IB2023/057425 WO2024023666A1 (en) 2022-07-26 2023-07-20 Crystalline forms of an akr1c3 dependent kars inhibitor

Publications (1)

Publication Number Publication Date
IL318382A true IL318382A (en) 2025-03-01

Family

ID=87571498

Family Applications (1)

Application Number Title Priority Date Filing Date
IL318382A IL318382A (en) 2022-07-26 2023-07-20 Crystalline forms of an akr1c3 dependent kars inhibitor

Country Status (11)

Country Link
US (1) US20250353847A1 (en)
EP (1) EP4562010A1 (en)
JP (1) JP2025524064A (en)
KR (1) KR20250040692A (en)
CN (1) CN119301125A (en)
AU (1) AU2023314354A1 (en)
CA (1) CA3259169A1 (en)
IL (1) IL318382A (en)
MX (1) MX2025000947A (en)
TW (1) TW202409035A (en)
WO (1) WO2024023666A1 (en)

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2779780A (en) 1955-03-01 1957-01-29 Du Pont 1, 4-diamino-2, 3-dicyano-1, 4-bis (substituted mercapto) butadienes and their preparation
JP2002532415A (en) 1998-12-16 2002-10-02 ワーナー−ランバート・カンパニー Treatment of arthritis with MEK inhibitors
AU7349801A (en) 2000-07-19 2002-01-30 Warner Lambert Co Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
WO2004007529A2 (en) 2002-07-15 2004-01-22 The Trustees Of Princeton University Iap binding compounds
EP1478648B1 (en) 2002-02-01 2014-04-30 ARIAD Pharmaceuticals, Inc. Phosphorus-containing compounds and uses thereof
CA2478065C (en) 2002-03-08 2013-01-08 Eisai Co. Ltd. Macrocyclic compounds useful as pharmaceuticals
TWI275390B (en) 2002-04-30 2007-03-11 Wyeth Corp Process for the preparation of 7-substituted-3- quinolinecarbonitriles
GB0215823D0 (en) 2002-07-09 2002-08-14 Astrazeneca Ab Quinazoline derivatives
US7399865B2 (en) 2003-09-15 2008-07-15 Wyeth Protein tyrosine kinase enzyme inhibitors
BRPI0506883A (en) 2004-01-16 2007-05-29 Univ Michigan conformational compressed smac mimetics and their uses
CN1933847A (en) 2004-01-16 2007-03-21 密歇根大学董事会 SMAC peptidomimetics and the uses thereof
US7345081B2 (en) 2004-03-23 2008-03-18 Genentech, Inc. Azabicyclo-octane inhibitors of IAP
PL2253614T3 (en) 2004-04-07 2013-03-29 Novartis Ag Inhibitors of IAP
KR100926203B1 (en) 2004-07-02 2009-11-09 제넨테크, 인크. Inhibitors of IAP
WO2006010118A2 (en) 2004-07-09 2006-01-26 The Regents Of The University Of Michigan Conformationally constrained smac mimetics and the uses thereof
BRPI0513310A (en) 2004-07-12 2008-05-06 Idun Pharmaceuticals Inc tetrapeptide analogs
JP5230865B2 (en) 2004-07-15 2013-07-10 テトラロジック ファーマシューティカルズ コーポレーション IAP binding compound
MX2007007195A (en) 2004-12-20 2007-10-08 Genentech Inc Pyrrolidine inhibitors of iap.
MX2008002114A (en) 2005-07-21 2008-04-17 Ardea Biosciences Inc N-(arylamino)-sulfonamide inhibitors of mek.
NZ598890A (en) 2007-04-30 2013-10-25 Genentech Inc Inhibitors of iap
BRPI0816769A2 (en) 2007-09-12 2016-11-29 Hoffmann La Roche combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
WO2009055730A1 (en) 2007-10-25 2009-04-30 Genentech, Inc. Process for making thienopyrimidine compounds
US8168784B2 (en) 2008-06-20 2012-05-01 Abbott Laboratories Processes to make apoptosis promoters
UY38806A (en) 2019-08-01 2021-02-26 Novartis Ag AKR1C3-DEPENDENT KARS TRICYCLIC INHIBITOR COMPOUNDS, COMPOSITIONS AND THEIR USES

Also Published As

Publication number Publication date
MX2025000947A (en) 2025-03-07
CN119301125A (en) 2025-01-10
CA3259169A1 (en) 2024-02-01
AU2023314354A1 (en) 2024-11-21
US20250353847A1 (en) 2025-11-20
KR20250040692A (en) 2025-03-24
EP4562010A1 (en) 2025-06-04
WO2024023666A1 (en) 2024-02-01
TW202409035A (en) 2024-03-01
JP2025524064A (en) 2025-07-25

Similar Documents

Publication Publication Date Title
IL285493A (en) Crystalline forms of an rsk inhibitor
IL316075A (en) Crystalline form of lanifibranor
SI4058453T1 (en) Improved synthesis of kras g12c inhibitor compound
ZA202106766B (en) Compounds as inhibitors of macrophage migration inhibitory factor
IL287792A (en) Tricyclic akr1c3 dependent kars inhibitors
IL314049A (en) Parp7 inhibitors
EP4582427A4 (en) Usp1 inhibitor
EP3870181A4 (en) CRYSTALLINE FORMS OF AN ALK2 INHIBITOR
EP3923948A4 (en) Crystalline forms of a jak2 inhibitor
IL320747A (en) Piperidine derivatives as mettl3 inhibitors
IL317006A (en) Prodrugs of stat3 inhibitors
EP3996707A4 (en) CRYSTALLINE FORMS OF PLASMA KALLICREIN INHIBITORS
GB202307924D0 (en) Inhibitor compounds
GB202300881D0 (en) Inhibitor compounds
HK40120423A (en) Crystalline forms of an akr1c3 dependent kars inhibitor
IL326113A (en) Methods of using factor B inhibitors
IL319472A (en) Physical forms of an inhibitor of prc2
EP3927704A4 (en) Crystalline forms of a jak2 inhibitor
EP4479051A4 (en) CRYSTALLINE (+)-TETRABENAZINE
GB202014196D0 (en) Crystalline form III of tetraacetylethylenediamine
SMT202600195T1 (en) Crystalline forms of evenamide
MX2025000947A (en) Crystalline forms of an akr1c3 dependent kars inhibitor
CA3287070A1 (en) Crystalline forms of an azetidine parp1 inhibitor
CA3288524A1 (en) Crystalline forms of evenamide
CA3258544A1 (en) Methods of tricyclic akr1c3 dependent kars inhibitor dosing